UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 1, 2003
STAAR SURGICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware 0-11634 95-3797439
(State or other jurisdiction (Commission File Number) (I.R.S. Employer
of incorporation or organization) Identification No.)
1911 Walker Avenue, Monrovia, California 91016
(Address of principal executive offices) (Zip Code)
(626) 303-7902
(Registrant's telephone number, including area code)
Item 7. Financial Statements and Exhibits
(c) Exhibits
Exhibit Number Description
-------------- -----------
99.1 Press Release dated May 1, 2003.
99.2 Transcript of conference call held May 1, 2002.
Item 9. Regulation FD Disclosure
Results of Operations and Financial Condition
---------------------------------------------
In accordance with SEC Release No. 34-47583, the following information,
intended to be furnished under "Item 12. Results of Operations and Financial
Condition," is instead furnished under this "Item 9. Regulation FD Disclosure."
This information will not be treated as "filed" for the purposes of Section 18
of the Securities Exchange Act of 1934 or otherwise subject to the liabilities
of that section. This information will not be incorporated by reference into a
filing under the Securities Act of 1933, or into another filing under the
Exchange Act, unless that filing expressly refers to specific information in
this report.
On May 1, 2003, STAAR Surgical Company issued a press release announcing
financial results for the first fiscal quarter of 2003. A copy is attached as
Exhibit 99.1 to this report and is incorporated herein by this reference.
On May 1, 2003, STAAR Surgical Company held an earnings conference call to
discuss the financial results for the first fiscal quarter of 2003. A transcript
of the presentation given by David Bailey and John Bily and the related question
and answer session in the call is attached to this report as Exhibit 99.2 and is
incorporated herein by this reference.
-2-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: May 5, 2003 STAAR SURGICAL COMPANY
By: /s/ John Bily
___________________
John Bily
Chief Financial Officer
-3-
Exhibit Index
EXHIBIT NUMBER DESCRIPTION
-------------- -----------
99.1 Press Release dated May 1, 2003.
99.2 Transcript of conference call held May 1, 2002.
-4-